BTLA Antibody from ROCKLAND IMMUNOCHEMICALS INC.
Search, find, compare suppliers for anti-BTLA antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | BTLA |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | immunoaffinity purified |
| Size | 100 µg |
| Concentration | 1.0 mg/ml |
| Applications | ELISA, Immunohistochemistry, IF Microscopy, Western Blot |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-BTLA Antibody was affinity purified from monospecific antiserum by immunoaffinity chromatography. BTLA antibody is human specific. At least two isoforms of BTLA are known to exist. The B- and T-lymphocyte attenuator (BTLA) protein is a member of the immunoglobulin superfamily containing a single immunoglobulin (Ig) domain. Like other coihibitory receptors such as CTLA-4 and PD-1, BTLA functions as a receptor that relays inhibitory signals to suppress the immune response, and can inhibit LPS-induced endotoxic shock by suppressing TLR4 signaling in innate immune cells. Polymorphisms in this gene have also been associated with an increased risk of rheumatoid arthritis. |
| Immunogen | Anti-BTLA antibody was prepared from whole rabbit serum produced by repeated immunizations with a 17 amino acid peptide near the internal region of human BTLA. |
| Other Names | BTLA Antibody , BTLA1, CD272, B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein |
| Gene, Accession # | BTLA, Gene ID: 151888, NCBI: NP_861445, UniProt: Q7Z6A9 |
| Catalog # | 600-401-Z97 |
| Price | $475 |
| Order / More Info | BTLA Antibody from ROCKLAND IMMUNOCHEMICALS INC. |
| Product Specific References | n/a |
ROCKLAND IMMUNOCHEMICALS INC.
ROCKLAND IMMUNOCHEMICALS INC.
PO Box 5199
Limerick PA 19468
P: 484-791-3823
P: 800.656.7625
F: 484.369.8654
orders@rockland.com
Technical Support: tech@rockland.com
https://www.rockland.com/
Profile of ROCKLAND IMMUNOCHEMICALS INC.
Return to Antibodies